Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets.

[1]  C. Lowik,et al.  Dose-dependent effects of phytoestrogens on bone , 2005, Trends in Endocrinology & Metabolism.

[2]  E. Çakır,et al.  Systemic Markers of Lipid Peroxidation and Antioxidants in Patients with Nonalcoholic Fatty Liver Disease , 2005, The American Journal of Gastroenterology.

[3]  T. Asano,et al.  Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. , 2005, Diabetes.

[4]  E. Rimm,et al.  Prospective Study on Usual Dietary Phytoestrogen Intake and Cardiovascular Disease Risk in Western Women , 2005, Circulation.

[5]  S. Ho,et al.  Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. , 2005, The American journal of clinical nutrition.

[6]  A. Cederbaum,et al.  A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  W. Frishman,et al.  Phytoestrogens as Cardioprotective Agents , 2005, Cardiology in review.

[8]  G. Marchesini,et al.  Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. , 2004, Best practice & research. Clinical gastroenterology.

[9]  T. Wilt,et al.  Phytoestrogens for Treatment of Menopausal Symptoms: A Systematic Review , 2004, Obstetrics and gynecology.

[10]  J. Merritt.  Metabolic syndrome: soybean foods and serum lipids. , 2004, Journal of the National Medical Association.

[11]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[12]  S. Donovan,et al.  Genistein at a concentration present in soy infant formula inhibits Caco-2BBe cell proliferation by causing G2/M cell cycle arrest. , 2004, The Journal of nutrition.

[13]  J. Kim,et al.  Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα , 2004, Molecular and Cellular Endocrinology.

[14]  J. Romijn,et al.  Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  I. Raskin,et al.  Dietary phytoestrogens and health. , 2004, Phytochemistry.

[16]  Y. Igarashi,et al.  Regulative actions of dietary soy isoflavone on biological antioxidative system and lipid metabolism in rats. , 2004, Journal of agricultural and food chemistry.

[17]  S. Soltoff.  Evidence That Tyrphostins AG10 and AG18 Are Mitochondrial Uncouplers That Alter Phosphorylation-dependent Cell Signaling* , 2004, Journal of Biological Chemistry.

[18]  K. Mak,et al.  Model of nonalcoholic steatohepatitis. , 2004, The American journal of clinical nutrition.

[19]  M. Chiang,et al.  The effect of high‐fat and high‐fructose diets on glucose tolerance and plasma lipid and leptin levels in rats , 2004, Diabetes, obesity & metabolism.

[20]  B. Miroux,et al.  The biology of mitochondrial uncoupling proteins. , 2004, Diabetes.

[21]  S. Eaton,et al.  Mitochondrial beta-oxidation. , 2004, European journal of biochemistry.

[22]  F. Kraemer,et al.  Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[23]  R. Blair,et al.  Soy Protein With Isoflavones, but not an Isoflavone-Rich Supplement, Improves Arterial Low-Density Lipoprotein Metabolism and Atherogenesis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[24]  G. Gores,et al.  Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. , 2003, Journal of hepatology.

[25]  Y. Terauchi,et al.  Molecular Mechanism of Insulin Resistance and Obesity , 2003, Experimental biology and medicine.

[26]  D. Lubahn,et al.  The soy isoflavone genistein decreases adipose deposition in mice. , 2003, Endocrinology.

[27]  J. Rocha,et al.  A High Fat Diet Inhibits δ-Aminolevulinate Dehydratase and Increases Lipid Peroxidation in Mice (Mus musculus) , 2003 .

[28]  W. Banz,et al.  Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. , 2003, The Journal of nutrition.

[29]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[30]  L. Lemberg,et al.  Obesity and the metabolic syndrome. , 2003, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[31]  A. Brunati,et al.  Interaction of genistein with the mitochondrial electron transport chain results in opening of the membrane transition pore. , 2002, Biochimica et biophysica acta.

[32]  J. Hodgin,et al.  The Atheroprotective Effect of Dietary Soy Isoflavones in Apolipoprotein E−/− Mice Requires the Presence of Estrogen Receptor-&agr; , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[33]  P. Besnard,et al.  Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse DOI 10.1194/jlr.M20008-JLR200 , 2002, Journal of Lipid Research.

[34]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[35]  D. Ross,et al.  Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. , 2002, American journal of physiology. Endocrinology and metabolism.

[36]  N. Stern,et al.  Effects of phytoestrogens on DNA synthesis and creatine kinase activity in vascular cells. , 2001, American journal of hypertension.

[37]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[38]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[39]  M. Anthony,et al.  Effects of soy isoflavones on atherosclerosis: potential mechanisms. , 1998, The American journal of clinical nutrition.

[40]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[41]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[42]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[43]  P. Owen,et al.  Factors influencing the activity of succinate dehydrogenase in membrane preparations from Micrococcus lysodeikticus. , 1970, The Biochemical journal.

[44]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[45]  F. Pfannkuch,et al.  Acute, subchronic and chronic safety studies with genistein in rats. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[46]  Insuk Sohn,et al.  Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. , 2005, The Journal of nutrition.

[47]  C. Champagne,et al.  Obesity and the Metabolic Syndrome: implications for dietetics practitioners. , 2004, Journal of the American Dietetic Association.

[48]  M. Anthony,et al.  Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. , 2001, The Journal of clinical endocrinology and metabolism.

[49]  J. Le Pecq,et al.  Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. , 1990, Biochemical pharmacology.

[50]  A. Tzagoloff,et al.  [45] Cytochrome oxidase from beef heart mitochondria , 1967 .